Skip to content
Breaking News

Breaking News

  • Home
  • World
  • Business
  • Health
  • Entertainment
  • Life Style
  • Sports
  • Toggle search form
Forget Anthropic: In Europe, the IPO hype is about a blue lagoon

Forget Anthropic: In Europe, the IPO hype is about a blue lagoon

Posted on November 20, 2026 By Admin No Comments on Forget Anthropic: In Europe, the IPO hype is about a blue lagoon


People bathing in The Blue Lagoon, a geothermal bath resort in the south of Iceland.

Getty Images

While investors are fixated on Anthropic’s blockbuster stock market debut, a very different IPO is making waves in Europe: Iceland’s Blue Lagoon, the operator of one of the world’s most famous geothermal spas.

Blue Lagoon Corp. raised roughly 14.3 billion Icelandic kronur ($110 million) through the offering, valuing the Icelandic geothermal spa operator at about $787 million, according to the company’s investor presentation.

The Blue Lagoon traces its origins to 1992, when Blue Lagoon Ltd. was founded to study the water in the Blue Lagoon, an open-air pool of warm, milky-blue water set in a black lava field in southwestern Iceland. It grew into a business spanning a spa, hotels and skincare made with ingredients from the lagoon.

Shares will trade under the ticker “BLUE” on one of Europe’s smallest stock exchanges, Nasdaq Iceland Main Market, part of the Nasdaq Nordic group, which also operates exchanges in Sweden, Denmark and Finland.

‘Wellness is the new luxury’

“Wellness is the new luxury, and we know that the wellness economy is growing faster than the economy as a whole, so we have tailwind from that,” CEO Sigríður Margrét Oddsdóttir told CNBC on Thursday.

“Now is the right time for us to list,” she added. “We are a company that thinks long-term, we have a clear vision for the next decade, and being publicly listed gives investors the opportunity to participate in our journey.”

The company’s operations are centered on Iceland’s Reykjanes Peninsula, where, as well as the Blue Lagoon geothermal spa, it runs the Silica Hotel, the Retreat luxury hotel and spa, and the Michelin-starred Moss restaurant. 

It also operates the Kerlingarfjöll Highland Base and Hrauneyjar properties in Iceland’s highlands, and sells Blue Lagoon-branded skincare products internationally.

The 34-year-old company has averaged 11% annual revenue growth over the past decade, and next year is expected to be a record, with revenue growing by more than half, Oddsdóttir said.

The company plans to use the raised capital to fund expanding its existing properties, acquiring businesses, and developing new destinations.

In total, nearly 4,000 subscriptions were received in the initial public offering, worth about 15.3 billion kronur, about 7% more than the total size of the offering, the company said, citing strong demand from smaller investors, including retail investors.

Iceland’s relatively small stock market had just 27 companies on its main exchange at the end of 2025, according to Nasdaq. The market is dominated by banks, seafood companies and other domestically focused firms.

Iceland’s growing wellness industry

The global wellness industry reached $7.5 trillion in 2025, up 8.9% from the previous year, according to the Global Wellness Institute. Spending on thermal and mineral springs grew 10.4% over the same period, with the institute forecasting annual growth of nearly 10% for the sector through 2030.

Tourism accounted for nearly 9% of Iceland’s GDP in 2025, and is growing, according to Statistics Iceland. The country welcomed around 2.3 million international visitors that year, with the U.S. as its largest source market.



Source link

Health Tags:Business, business news, Health care industry, Iceland, IPO

Post navigation

Previous Post: Meghan Markle kicks off festive season with good news for fans

More Related Articles

Cruise ship linked to deadly hantavirus outbreak arrives off Tenerife as passenger evacuation begins Cruise ship linked to deadly hantavirus outbreak arrives off Tenerife as passenger evacuation begins Health
Follistatin-344: A Regulatory Peptide in Growth Factor and Experimental Biology Research – SUCH TV Follistatin-344: A Regulatory Peptide in Growth Factor and Experimental Biology Research – SUCH TV Health
New COVID subvariant, Eris, is now most common and fastest-spreading in US: ‘Never going away’ New COVID subvariant, Eris, is now most common and fastest-spreading in US: ‘Never going away’ Health
New Wegovy pill offers needle-free weight loss — but may not work for everyone New Wegovy pill offers needle-free weight loss — but may not work for everyone Health
Peloton shares jump as it partners with TikTok on fitness content Peloton shares jump as it partners with TikTok on fitness content Health
Gummy vitamins sold at major retailers recalled by FDA due to health concerns Gummy vitamins sold at major retailers recalled by FDA due to health concerns Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Forget Anthropic: In Europe, the IPO hype is about a blue lagoon
  • Meghan Markle kicks off festive season with good news for fans
  • SpiceJet is cancelling over half its scheduled flights daily, leaving passengers stranded as DGCA stops short of restricting bookings; cash-strapped airline races to raise Rs 5,500 crore
  • The U.S. has lost measles elimination status. Here’s what that means and who is most at risk.
  • Which areas have the most jobs for 16-24 year-olds? Use our look-up to find out

Categories

  • Business
  • Entertainment
  • Health
  • Life Style
  • Sports
  • World

Copyright © 2026 Breaking News.

Powered by PressBook Blog WordPress theme